AVBP peer analysis
ArriVent BioPharma (AVBP) against its competitors: price, today's move, 1-year return and market value side by side.
AVBP and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BDTX Black Diamond | $1.73 | 4.22% | -55.04% | $99.97M |
| ERAS Erasca | $14.57 | 9.80% | 559.55% | – |
| EXEL Exelixis | $69.57 | 1.25% | 72.29% | $16.97B |
| HCM HUTCHMED | $14.20 | 2.01% | -8.80% | $2.48B |
| IDYA IDEAYA Biosciences | $31.24 | 1.92% | 5.36% | $2.75B |
| NUVB Nuvation Bio | $4.19 | 0.00% | -15.45% | – |
| ORIC Oric | $8.82 | 3.89% | -28.84% | $913.18M |
| PBYI Puma Biotechnology | $7.96 | -18.51% | 66.73% | $425.61M |
| TYRA Tyra Biosciences | $21.15 | 1.24% | 42.65% | – |
| ZLAB Zai Lab | $25.10 | 11.06% | 2.74% | $2.90B |
| AVBP ArriVent BioPharma | $13.52 | 10.58% | -25.53% | – |
- AVBP's peers: BDTX (Black Diamond), ERAS (Erasca), EXEL (Exelixis), HCM (HUTCHMED), IDYA (IDEAYA Biosciences), NUVB (Nuvation Bio), ORIC (Oric), PBYI (Puma Biotechnology).
Updated 2026-11-07 11:54 UTC